179 related articles for article (PubMed ID: 34151251)
21. Revealing the roles of polymers in supersaturation stabilization from the perspective of crystallization behaviors: A case of nimodipine.
Zhao P; Hu G; Chen H; Li M; Wang Y; Sun N; Wang L; Xu Y; Xia J; Tian B; Liu Y; He Z; Fu Q
Int J Pharm; 2022 Mar; 616():121538. PubMed ID: 35124119
[TBL] [Abstract][Full Text] [Related]
22. Structural Elucidation of Poloxamer 237 and Poloxamer 237/Praziquantel Solid Dispersions: Impact of Poly(Vinylpyrrolidone) over Drug Recrystallization and Dissolution.
Orlandi S; Priotti J; Diogo HP; Leonardi D; Salomon CJ; Nunes TG
AAPS PharmSciTech; 2018 Apr; 19(3):1274-1286. PubMed ID: 29313262
[TBL] [Abstract][Full Text] [Related]
23. Amorphous stabilization and dissolution enhancement of amorphous ternary solid dispersions: combination of polymers showing drug-polymer interaction for synergistic effects.
Prasad D; Chauhan H; Atef E
J Pharm Sci; 2014 Nov; 103(11):3511-3523. PubMed ID: 25196860
[TBL] [Abstract][Full Text] [Related]
24. Physicochemical characterization of hot melt extruded bicalutamide-polyvinylpyrrolidone solid dispersions.
Andrews GP; AbuDiak OA; Jones DS
J Pharm Sci; 2010 Mar; 99(3):1322-35. PubMed ID: 19798757
[TBL] [Abstract][Full Text] [Related]
25. Impact of surfactants on the crystal growth of amorphous celecoxib.
Mosquera-Giraldo LI; Trasi NS; Taylor LS
Int J Pharm; 2014 Jan; 461(1-2):251-7. PubMed ID: 24333451
[TBL] [Abstract][Full Text] [Related]
26. Influence of Low-Molecular-Weight Excipients on the Phase Behavior of PVPVA64 Amorphous Solid Dispersions.
Lehmkemper K; Kyeremateng SO; Degenhardt M; Sadowski G
Pharm Res; 2018 Jan; 35(1):25. PubMed ID: 29305717
[TBL] [Abstract][Full Text] [Related]
27. Development of stability-enhanced ternary solid dispersions via combinations of HPMCP and Soluplus
Albadarin AB; Potter CB; Davis MT; Iqbal J; Korde S; Pagire S; Paradkar A; Walker G
Int J Pharm; 2017 Oct; 532(1):603-611. PubMed ID: 28923766
[TBL] [Abstract][Full Text] [Related]
28. Ball milling and hot-melt extrusion of indomethacin-l-arginine-vinylpyrrolidone-vinyl acetate copolymer: Solid-state properties and dissolution performance.
Iemtsev A; Zemánková A; Hassouna F; Mathers A; Klajmon M; Slámová M; Malinová L; Fulem M
Int J Pharm; 2022 Feb; 613():121424. PubMed ID: 34968683
[TBL] [Abstract][Full Text] [Related]
29. Understanding the generation and maintenance of supersaturation during the dissolution of amorphous solid dispersions using modulated DSC and
Baghel S; Cathcart H; O'Reilly NJ
Int J Pharm; 2018 Jan; 536(1):414-425. PubMed ID: 29183857
[TBL] [Abstract][Full Text] [Related]
30. Five-Stage Approach for a Systematic Screening and Development of Etravirine Amorphous Solid Dispersions by Hot-Melt Extrusion.
Simões MF; Pereira A; Cardoso S; Cadonau S; Werner K; Pinto RMA; Simões S
Mol Pharm; 2020 Feb; 17(2):554-568. PubMed ID: 31774685
[TBL] [Abstract][Full Text] [Related]
31. Hydroxypropyl cellulose stabilizes amorphous solid dispersions of the poorly water soluble drug felodipine.
Sarode AL; Malekar SA; Cote C; Worthen DR
Carbohydr Polym; 2014 Nov; 112():512-9. PubMed ID: 25129775
[TBL] [Abstract][Full Text] [Related]
32. Use of surfactants as plasticizers in preparing solid dispersions of poorly soluble API: selection of polymer-surfactant combinations using solubility parameters and testing the processability.
Ghebremeskel AN; Vemavarapu C; Lodaya M
Int J Pharm; 2007 Jan; 328(2):119-29. PubMed ID: 16968659
[TBL] [Abstract][Full Text] [Related]
33. Formulation and characterization of ternary solid dispersions made up of Itraconazole and two excipients, TPGS 1000 and PVPVA 64, that were selected based on a supersaturation screening study.
Janssens S; Nagels S; Armas HN; D'Autry W; Van Schepdael A; Van den Mooter G
Eur J Pharm Biopharm; 2008 May; 69(1):158-66. PubMed ID: 18164929
[TBL] [Abstract][Full Text] [Related]
34. Effect of Temperature and Moisture on the Physical Stability of Binary and Ternary Amorphous Solid Dispersions of Celecoxib.
Xie T; Taylor LS
J Pharm Sci; 2017 Jan; 106(1):100-110. PubMed ID: 27476771
[TBL] [Abstract][Full Text] [Related]
35. Investigating the Potential of Ethyl Cellulose and a Porosity-Increasing Agent as a Carrier System for the Formulation of Amorphous Solid Dispersions.
Everaerts M; Cools L; Adriaensens P; Reekmans G; Baatsen P; Van den Mooter G
Mol Pharm; 2022 Aug; 19(8):2712-2724. PubMed ID: 35476407
[TBL] [Abstract][Full Text] [Related]
36. Viewing Molecular and Interface Interactions of Curcumin Amorphous Solid Dispersions for Comprehending Dissolution Mechanisms.
Li J; Wang X; Li C; Fan N; Wang J; He Z; Sun J
Mol Pharm; 2017 Aug; 14(8):2781-2792. PubMed ID: 28661679
[TBL] [Abstract][Full Text] [Related]
37. Formulation of fast disintegrating tablets of ternary solid dispersions consisting of TPGS 1000 and HPMC 2910 or PVPVA 64 to improve the dissolution of the anti-HIV drug UC 781.
Goddeeris C; Willems T; Van den Mooter G
Eur J Pharm Sci; 2008 Aug; 34(4-5):293-302. PubMed ID: 18602800
[TBL] [Abstract][Full Text] [Related]
38. Phase Behavior of Amorphous Solid Dispersions of Felodipine: Homogeneity and Drug-Polymer Interactions.
Sarpal K; Delaney S; Zhang GGZ; Munson EJ
Mol Pharm; 2019 Dec; 16(12):4836-4851. PubMed ID: 31682129
[TBL] [Abstract][Full Text] [Related]
39. Orally Disintegrating Tablets Containing Melt Extruded Amorphous Solid Dispersion of Tacrolimus for Dissolution Enhancement.
Ponnammal P; Kanaujia P; Yani Y; Ng WK; Tan RBH
Pharmaceutics; 2018 Mar; 10(1):. PubMed ID: 29547585
[TBL] [Abstract][Full Text] [Related]
40. Forced Solid-State Oxidation Studies of Nifedipine-PVP Amorphous Solid Dispersion.
Saraf I; Roskar R; Modhave D; Brunsteiner M; Karn A; Neshchadin D; Gescheidt G; Paudel A
Mol Pharm; 2022 Feb; 19(2):568-583. PubMed ID: 35060741
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
